Literature DB >> 3570143

Morphological changes after intra-arterial chemotherapy of the liver.

G Herrmann, M Lorenz, M Kirkowa-Reimann, C Hottenrott, K Hübner.   

Abstract

The livers of twenty patients given intra-arterial chemotherapy to treat malignant tumors of the liver or liver metastases, were examined histologically. The results show that cytostatic chemotherapy primarily affects tumor cells, but also causes toxic damage to liver tissue. Besides necrosis of single cells or groups of cells and cholestasis in about one-third of the cases sclerosing cholangitis is a major complication. After chemoembolization, which produces a more marked therapeutic effect with regard to tumor necrosis, extensive necrosis of liver tissue, arteries, bile ducts, and nerves is most conspicuous. Nevertheless, in view of the positive therapeutic effects observed, intra-arterial chemotherapy is recommended for palliative therapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3570143

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Benign nontraumatic inflammatory stricture of mid portion of common bile duct mimicking malignant tumor: Report of two cases.

Authors:  Chiu-Yung Ho; Tseng-Shing Chen; Full-Young Chang; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

2.  [Regional chemotherapy of liver metastases].

Authors:  A Encke; C Hottenrott; M Lorenz
Journal:  Langenbecks Arch Chir       Date:  1987

Review 3.  [What is the value of arterial chemotherapy in treatment of colorectal liver metastases].

Authors:  M Lorenz; A Encke
Journal:  Langenbecks Arch Chir       Date:  1994

4.  Management and outcome in patients with Klatskin-mimicking lesions of the biliary tree.

Authors:  Dirk Uhlmann; Marcus Wiedmann; Frank Schmidt; Regine Kluge; Andrea Tannapfel; Frieder Berr; Johann Hauss; Helmut Witzigmann
Journal:  J Gastrointest Surg       Date:  2006 Sep-Oct       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.